Invention Grant
- Patent Title: Forms of rifaximin and uses thereof
-
Application No.: US14062333Application Date: 2013-10-24
-
Publication No.: US09273066B2Publication Date: 2016-03-01
- Inventor: Karen S. Gushurst , Donglai Yang , Petinka Vlahova , Jeffrey S. Stults
- Applicant: Salix Pharmaceuticals, Ltd
- Applicant Address: US NC Raleigh
- Assignee: Salix Pharmaceuticals, Inc.
- Current Assignee: Salix Pharmaceuticals, Inc.
- Current Assignee Address: US NC Raleigh
- Agency: McCarter English LLP
- Agent Jonathan M. Sparks; Michael J. DeGrazia
- Main IPC: C07D498/22
- IPC: C07D498/22 ; C07D498/12
Abstract:
The present invention relates to Rifaximin polymorphic forms, to their use in medicinal preparations and to therapeutic methods using them.
Public/Granted literature
- US20140179916A1 FORMS OF RIFAXIMIN AND USES THEREOF Public/Granted day:2014-06-26
Information query
